About Wayne State University; Department of Neurology
Clinical Trials at Wayne State University; Department of Neurology
During the past decade, Wayne State University; Department of Neurology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Wayne State University; Department of Neurology" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Acorda Therapeutics" with 3 trials
sponsored, "Genentech, Inc." with 2 trials sponsored, "Genzyme, a Sanofi Company" with 2 trials sponsored and "Cyberonics, Inc."
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Wayne State University; Department of Neurology"
#1 collaborator was "Bayer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Wayne State University; Department of Neurology
According to Clinical.Site data, the most researched conditions in "Wayne State University; Department of Neurology" are
"Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Relapsing Multiple Sclerosis" (2 trials), "Epilepsies, Partial" (1 trials) and "Multiple Sclerosis (MS)" (1 trials). Many other conditions were trialed in "Wayne State University; Department of Neurology" in a lesser frequency.
Clinical Trials Intervention Types at Wayne State University; Department of Neurology
Most popular intervention types in "Wayne State University; Department of Neurology" are "Drug" (9 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (5 trials), "Fampridine-SR" (3 trials), "Interferon beta-1a" (3 trials), "Placebo" (3 trials) and "Alemtuzumab 12 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Wayne State University; Department of Neurology
The vast majority of trials in "Wayne State University; Department of Neurology" are
12 trials for "All" genders.
Clinical Trials Status at Wayne State University; Department of Neurology
Currently, there are NaN active trials in "Wayne State University; Department of Neurology".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Wayne State University; Department of Neurology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Wayne State University; Department of Neurology, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".